The Federal Trade Commission has released its second report digging into how the business practices of pharmacy benefit managers could be inflating drug costs in the U.S., in the latest and likely last salvo between antitrust regulators in the Biden administration and the controversial middlemen in the drug supply chain. The report accuses CVS’ Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx of jacking up the price of lifesaving drugs by hundreds and thousands of percent. The so-called “Big Three” PBMs also directed the most profitable prescriptions to affiliated pharmacies at the expense of independent operators, and paid themselves more than other pharmacies for dispensing drugs, the report says.
Read the full article: FTC Releases Second Report Slamming Pharmacy Benefit Managers //
Source: https://www.healthcaredive.com/news/ftc-second-pharmacy-benefit-manager-report-caremark-express-scripts-unitedhealth/737249